Head-to-head dispatch
MyDrHank vs Vytora Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Every price MyDrHank advertises is the cheapest rung of a four-term ladder — its own code renders the annual-prepay rate as “From $X/mo”, so the month-to-month cost of $349 tirzepatide and $259 semaglutide appears nowhere in the marketing.
Marked down on: Every advertised price is an annual-prepay minimum. The site's own code takes the cheapest rung of a four-term ladder and prints it as “From $X/mo”, so the $240/mo tirzepatide and $171/mo semaglutide it markets are what $2,883 and $2,057 paid up front work out to per month — the month-to-month rates, $349 and $249, are displayed nowhere, and the FAQ still calls the prepay figure a plan with “no contract”
Desk Score
Low flat pricing on both molecules with brand access and full nationwide reach — value without the state limits.
Marked down on: Injectable only — no oral route
Vytora Health takes this head-to-head with the higher Desk Score, 90/100 (A−) against 73/100 (C) for MyDrHank. MyDrHank still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
MyDrHank
73/100
C
Vytora Health
90/100
A−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | MyDrHank | Vytora Health |
|---|---|---|
| Semaglutide | $259/mo month-to-month (compounded injectable; oral $249/mo; the advertised $171/mo is a $2,057 annual prepay) | $150/mo |
| Tirzepatide | $349/mo month-to-month (compounded; the advertised $240/mo is a $2,883 annual prepay) | $200/mo |
| Coverage | 44 states (excludes Kansas, Louisiana, Mississippi, New Mexico, North Dakota, West Virginia) | All 50 states |
| Brand-name | Compounded only | Yes |
| Oral option | Yes | Injectable only |
| Best for | Readers who intend to pay for a full year up front and will do the arithmetic first — at the month-to-month rate this is one of the dearer compounded desks the Desk tracks. | Budget-minded patients who want brand access and all-50-state coverage in one place. |
| Desk Score | 73/100C | 90/100A− |
The verdict
Desk pick — Vytora HealthVytora Health takes this head-to-head with the higher Desk Score, 90/100 (A−) against 73/100 (C) for MyDrHank. MyDrHank still holds its ground where its strengths line up with yours.
Choose MyDrHank if…
Readers who intend to pay for a full year up front and will do the arithmetic first — at the month-to-month rate this is one of the dearer compounded desks the Desk tracks.
$259/mo month-to-month (compounded injectable; oral $249/mo; the advertised $171/mo is a $2,057 annual prepay) sema · $349/mo month-to-month (compounded; the advertised $240/mo is a $2,883 annual prepay) tirz · 44 states (excludes Kansas, Louisiana, Mississippi, New Mexico, North Dakota, West Virginia)
Choose Vytora Health if…
Budget-minded patients who want brand access and all-50-state coverage in one place.
$150/mo sema · $200/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: MyDrHank · Vytora Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- MyDrHank vs CoreAge Rx
- Vytora Health vs Vaylen
- MyDrHank vs Strut Health
- Vytora Health vs Ondra Health
- MyDrHank vs Invigor Medical
- Vytora Health vs Sesame Care
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.